Impact of initial coagulation and fibrinolytic markers on mortality in patients with severe blunt trauma: a multicentre retrospective observational study.


Journal

Scandinavian journal of trauma, resuscitation and emergency medicine
ISSN: 1757-7241
Titre abrégé: Scand J Trauma Resusc Emerg Med
Pays: England
ID NLM: 101477511

Informations de publication

Date de publication:
28 Feb 2019
Historique:
received: 04 12 2018
accepted: 19 02 2019
entrez: 2 3 2019
pubmed: 2 3 2019
medline: 16 4 2019
Statut: epublish

Résumé

Acute coagulopathy is a well-known predictor of poor outcomes in patients with severe trauma. However, using coagulation and fibrinolytic markers, how one can best predict mortality to find out potential candidates for treatment of coagulopathy remains unclear. This study aimed to determine preferential markers and their optimal cut-off values for mortality prediction. We conducted a retrospective observational study of patients with severe blunt trauma (injury severity score ≥ 16) transferred directly from the scene to emergency departments at two trauma centres in Japan from January 2013 to December 2015. We investigated the impact and optimal cut-off values of initial coagulation (platelet counts, fibrinogen and prothrombin time-international normalised ratio) and a fibrinolytic marker (D-dimer) on 28-day mortality via classification and regression tree (CART) analysis. Multivariate logistic regression analysis confirmed the importance of these markers. Receiver operating characteristic curve analyses were used to examine the prediction accuracy for mortality. Totally 666 patients with severe blunt trauma were analysed. CART analysis revealed that the initial discriminator was fibrinogen (cut-off, 130 mg/dL) and the second discriminator was D-dimer (cut-off, 110 μg/mL in the lower fibrinogen subgroup; 118 μg/mL in the higher fibrinogen subgroup). The 28-day mortality was 90.0% (lower fibrinogen, higher D-dimer), 27.8% (lower fibrinogen, lower D-dimer), 27.7% (higher fibrinogen, higher D-dimer) and 3.4% (higher fibrinogen, lower D-dimer). Multivariate logistic regression demonstrated that fibrinogen levels < 130 mg/dL (adjusted odds ratio [aOR], 9.55; 95% confidence interval [CI], 4.50-22.60) and D-dimer ≥110 μg/mL (aOR, 5.89; 95% CI, 2.78-12.70) were independently associated with 28-day mortality after adjusting for probability of survival by the trauma and injury severity score (TRISS Ps). Compared with the TRISS Ps alone (0.900; 95% CI, 0.870-0.931), TRISS Ps with fibrinogen and D-dimer yielded a significantly higher area under the curve (0.942; 95% CI, 0.920-0.964; p < 0.001). Fibrinogen and D-dimer were the principal markers for stratification of mortality in patients with severe blunt trauma. These markers could function as therapeutic targets because they were significant predictors of mortality, independent from severity of injury.

Sections du résumé

BACKGROUND BACKGROUND
Acute coagulopathy is a well-known predictor of poor outcomes in patients with severe trauma. However, using coagulation and fibrinolytic markers, how one can best predict mortality to find out potential candidates for treatment of coagulopathy remains unclear. This study aimed to determine preferential markers and their optimal cut-off values for mortality prediction.
METHODS METHODS
We conducted a retrospective observational study of patients with severe blunt trauma (injury severity score ≥ 16) transferred directly from the scene to emergency departments at two trauma centres in Japan from January 2013 to December 2015. We investigated the impact and optimal cut-off values of initial coagulation (platelet counts, fibrinogen and prothrombin time-international normalised ratio) and a fibrinolytic marker (D-dimer) on 28-day mortality via classification and regression tree (CART) analysis. Multivariate logistic regression analysis confirmed the importance of these markers. Receiver operating characteristic curve analyses were used to examine the prediction accuracy for mortality.
RESULTS RESULTS
Totally 666 patients with severe blunt trauma were analysed. CART analysis revealed that the initial discriminator was fibrinogen (cut-off, 130 mg/dL) and the second discriminator was D-dimer (cut-off, 110 μg/mL in the lower fibrinogen subgroup; 118 μg/mL in the higher fibrinogen subgroup). The 28-day mortality was 90.0% (lower fibrinogen, higher D-dimer), 27.8% (lower fibrinogen, lower D-dimer), 27.7% (higher fibrinogen, higher D-dimer) and 3.4% (higher fibrinogen, lower D-dimer). Multivariate logistic regression demonstrated that fibrinogen levels < 130 mg/dL (adjusted odds ratio [aOR], 9.55; 95% confidence interval [CI], 4.50-22.60) and D-dimer ≥110 μg/mL (aOR, 5.89; 95% CI, 2.78-12.70) were independently associated with 28-day mortality after adjusting for probability of survival by the trauma and injury severity score (TRISS Ps). Compared with the TRISS Ps alone (0.900; 95% CI, 0.870-0.931), TRISS Ps with fibrinogen and D-dimer yielded a significantly higher area under the curve (0.942; 95% CI, 0.920-0.964; p < 0.001).
CONCLUSIONS CONCLUSIONS
Fibrinogen and D-dimer were the principal markers for stratification of mortality in patients with severe blunt trauma. These markers could function as therapeutic targets because they were significant predictors of mortality, independent from severity of injury.

Identifiants

pubmed: 30819212
doi: 10.1186/s13049-019-0606-6
pii: 10.1186/s13049-019-0606-6
pmc: PMC6394102
doi:

Substances chimiques

Biomarkers 0
Fibrin Fibrinogen Degradation Products 0
fibrin fragment D 0
Fibrinogen 9001-32-5

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

25

Références

J Trauma. 2003 Jun;54(6):1127-30
pubmed: 12813333
J Trauma. 2003 Jul;55(1):39-44
pubmed: 12855879
Acta Haematol. 1957 Apr;17(4):237-46
pubmed: 13434757
Ann Behav Med. 2003 Dec;26(3):172-81
pubmed: 14644693
Crit Care Med. 1992 May;20(5):594-600
pubmed: 1533358
Trends Cardiovasc Med. 2005 Nov;15(8):302-8
pubmed: 16297768
J Trauma. 2006 Jun;60(6 Suppl):S3-11
pubmed: 16763478
Injury. 2007 Mar;38(3):298-304
pubmed: 17214989
Stat Med. 2008 Jan 30;27(2):157-72; discussion 207-12
pubmed: 17569110
Blood. 2009 Mar 26;113(13):2878-87
pubmed: 19008457
Crit Care. 2010;14(2):R55
pubmed: 20374650
J Thromb Haemost. 2010 Sep;8(9):1919-25
pubmed: 20553376
Lancet. 2010 Jul 3;376(9734):23-32
pubmed: 20554319
BMJ. 2011 Jul 01;343:d3795
pubmed: 21724564
Crit Care Med. 2011 Dec;39(12):2652-8
pubmed: 21765358
J Trauma. 2011 Aug;71(2 Suppl 3):S337-42
pubmed: 21814101
J Trauma. 1990 Nov;30(11):1356-65
pubmed: 2231804
PLoS One. 2012;7(3):e34457
pubmed: 22461913
J Thromb Haemost. 2012 Jul;10(7):1342-51
pubmed: 22519961
Ann Surg. 2012 Sep;256(3):476-86
pubmed: 22868371
J Thromb Haemost. 2013 Feb;11(2):307-14
pubmed: 23176206
J Am Coll Surg. 2013 Feb;216(2):290-7
pubmed: 23211116
JAMA Surg. 2013 Mar;148(3):218-25
pubmed: 23670117
BMC Emerg Med. 2013 Nov 22;13:20
pubmed: 24267513
Crit Care. 2014 Mar 26;18(2):R52
pubmed: 24666991
Crit Care. 2014 Apr 03;18(2):R61
pubmed: 24708802
Crit Care. 2014 Sep 27;18(5):518
pubmed: 25261079
Anesthesiology. 2015 Feb;122(2):241-75
pubmed: 25545654
Semin Thromb Hemost. 2015 Feb;41(1):35-42
pubmed: 25590522
Cochrane Database Syst Rev. 2015 Feb 16;(2):CD010438
pubmed: 25686465
J Neurotrauma. 2016 Apr 1;33(7):688-95
pubmed: 26414158
Shock. 2016 Mar;45(3):308-14
pubmed: 26882403
Crit Care. 2016 Apr 12;20:100
pubmed: 27072503
Sci Rep. 2018 Feb 28;8(1):3799
pubmed: 29491388
Anesth Analg. 1995 Aug;81(2):360-5
pubmed: 7542432

Auteurs

Kenta Ishii (K)

Department of Trauma and Critical Care, Rinku General Medical Centre, Senshu Trauma and Critical Care Centre, 2-23 Rinku Orai-kita, Izumisano, Osaka, 598-8577, Japan. ishiikenta0701@gmail.com.

Takahiro Kinoshita (T)

Division of Trauma and Surgical Critical Care, Osaka General Medical Centre, 3-1-56 Bandai-Higashi, Sumiyoshi-ku, Osaka, 558-8558, Japan.

Kazutaka Kiridume (K)

Department of Trauma and Critical Care, Rinku General Medical Centre, Senshu Trauma and Critical Care Centre, 2-23 Rinku Orai-kita, Izumisano, Osaka, 598-8577, Japan.

Atsushi Watanabe (A)

Division of Trauma and Surgical Critical Care, Osaka General Medical Centre, 3-1-56 Bandai-Higashi, Sumiyoshi-ku, Osaka, 558-8558, Japan.

Kazuma Yamakawa (K)

Division of Trauma and Surgical Critical Care, Osaka General Medical Centre, 3-1-56 Bandai-Higashi, Sumiyoshi-ku, Osaka, 558-8558, Japan.

Shota Nakao (S)

Department of Trauma and Critical Care, Rinku General Medical Centre, Senshu Trauma and Critical Care Centre, 2-23 Rinku Orai-kita, Izumisano, Osaka, 598-8577, Japan.

Satoshi Fujimi (S)

Division of Trauma and Surgical Critical Care, Osaka General Medical Centre, 3-1-56 Bandai-Higashi, Sumiyoshi-ku, Osaka, 558-8558, Japan.

Tetsuya Matsuoka (T)

Department of Trauma and Critical Care, Rinku General Medical Centre, Senshu Trauma and Critical Care Centre, 2-23 Rinku Orai-kita, Izumisano, Osaka, 598-8577, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH